Skip to main content

Shah Sujal's Form 4 filing

CymaBay Therapeutics, Inc. (CBAY) · filed Dec 11, 2023

Accession no.
0001062993-23-022368
Filed
Dec 11, 2023
Trade date
Dec 11, 2023
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.30M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Shah SujalCIK 0001588861Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 11, 2023Common StockMOption exerciseAcquired+63,975$5.00+$319,875235,276Direct
Dec 11, 2023Common StockSSaleDisposed−63,975$19.99−$1,278,860.25171,301Direct
Dec 11, 2023Common StockMOption exerciseAcquired+890$5.00+$4,450172,191Direct
Dec 11, 2023Common StockSSaleDisposed−890$20.81−$18,520.9171,301Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 11, 2023Common StockMOption exerciseDisposed−31,036$0.00$00Direct
Dec 11, 2023Common StockMOption exerciseDisposed−12,973$0.00$00Direct
Dec 11, 2023Common StockMOption exerciseDisposed−20,856$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)